Could a simple antioxidant ease COPD Flare-Ups?
NCT ID NCT07456176
First seen Mar 15, 2026 · Last updated Jun 08, 2026 · Updated 10 times
Summary
This study looks at whether a common antioxidant, alpha-lipoic acid (ALA), can help people hospitalized for a sudden worsening of COPD (a lung disease). Researchers will compare a low dose (600 mg) to a high dose (1200 mg) and a placebo, given alongside standard care. The goal is to see if ALA reduces inflammation and oxidative stress, and helps patients recover faster. The study plans to enroll 75 adults aged 40-70.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Matareya Teaching Hospital
Cairo, 11856, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.